Carcinoma, Mucoepidermoid
"Carcinoma, Mucoepidermoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)
MeSH Number(s)
C04.557.470.200.025.340
C04.557.470.590.340
Concept/Terms
Carcinoma, Mucoepidermoid- Carcinoma, Mucoepidermoid
- Carcinomas, Mucoepidermoid
- Mucoepidermoid Carcinoma
- Mucoepidermoid Carcinomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Mucoepidermoid".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Mucoepidermoid".
This graph shows the total number of publications written about "Carcinoma, Mucoepidermoid" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Mucoepidermoid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 0 | 3 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Carcinoma, Mucoepidermoid" by people in Profiles.
-
Cytopathology of primary sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a multi-institutional case series and review of literature. J Am Soc Cytopathol. 2024 Jan-Feb; 13(1):33-41.
-
Critical Appraisal of Histologic Grading for Mucoepidermoid Carcinoma of Salivary Gland: Is an Objective Prognostic 2-tiered Grading System Possible? Am J Surg Pathol. 2023 Nov 01; 47(11):1219-1229.
-
MAML2 Gene Rearrangement Occurs in Nearly All Hidradenomas: A Reappraisal in a Series of 20 Cases. Am J Dermatopathol. 2022 Nov 01; 44(11):806-811.
-
Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Mod Pathol. 2022 10; 35(10):1484-1493.
-
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. Int J Mol Sci. 2022 Apr 13; 23(8).
-
NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens. Am J Clin Pathol. 2022 Jan 06; 157(1):98-108.
-
Mucoacinar Carcinoma: A Rare Variant of Mucoepidermoid Carcinoma. Am J Surg Pathol. 2021 08 01; 45(8):1028-1037.
-
Diagnostic discrepancy in second opinion reviews of primary epithelial neoplasms involving salivary gland: An 11-year experience from a tertiary referral center focusing on useful pathologic approaches and potential clinical impacts. Head Neck. 2021 08; 43(8):2497-2509.
-
The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma. JCI Insight. 2021 04 08; 6(7).
-
NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics. Head Neck Pathol. 2021 Jun; 15(2):425-432.